Stocktoria

Earth Science Tech, Inc. ETST

OTC · OOTC · stock · Pharmaceutical Preparations · website · IPO 2012-08-29

Earth Science Tech, Inc. (ETST) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend. FY2026 revenue was $35.7M at a 10.2% net margin.

4/9
Piotroski F — financial health
Altman Z″ — distress risk
Dividend payout · no dividend
$0.15 as of 2026-06-01 · -21.1% 1y
$0.09$0.2452-wk

Price from month-end closes (Yahoo) — for reference, not real-time.

P / E12.7×
Net margin10.2%
Revenue trend · last 10y · up

How it ranks in Manufacturing · percentile among 1829 companies

Piotroski Fstronger than 44%
Net marginstronger than 79%
Return on equitystronger than 97%
Revenue growthstronger than 58%

Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.

Piotroski F breakdown · 4/9 tests passed

Detailed pages

Sector peers · similar-size Manufacturing companies

TickerCompanyPiotroski FAltman Z″P / ERevenue growth
ETSTEarth Science Tech, Inc.4/912.7+7.8%
VRCAVerrica Pharmaceuticals Inc.5/9-19.42
SBFMSunshine Biopharma Inc.4/9-1.63+4.1%
ZOMDFZomedica Corp.3/91.07+17.4%
VSTMVerastem, Inc.4/9-15.71+209.1%
FHTXFoghorn Therapeutics Inc.1/9-10.28+36.8%
BFRIBiofrontera Inc.1/9-15.24+11.7%

All Manufacturing companies →

FAQ

Is ETST financially healthy?

Earth Science Tech, Inc.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).

Does ETST pay a dividend?

No, Earth Science Tech, Inc. does not currently pay a dividend.

How profitable is ETST?

In FY2026, Earth Science Tech, Inc. had a net margin of 10.2% and a return on equity of 51.6%.

Source: SEC EDGAR filings · CIK 0001538495 · as of 2026-03-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.